Related Experiment Videos
Lung transplantation
1Department of Surgery, Ochsner Clinic, New Orleans, Louisiana, USA.
The Surgical Clinics of North America
|January 19, 1999
Summary
Lung transplant survival is improving, but infection and bronchiolitis obliterans remain major challenges. Controlling these issues is key to better long-term outcomes for lung transplant recipients.
Area of Science:
- Medicine
- Transplantation immunology
- Pulmonology
Background:
- Lung transplantation survival rates are improving but still lag behind other solid organ transplants.
- The lung allograft's environmental exposure makes it highly susceptible to infection, a primary cause of morbidity and mortality.
- Bronchiolitis obliterans syndrome (BOS) is a leading cause of late graft failure and is currently untreatable.
Purpose of the Study:
- To review the current status of lung transplantation outcomes.
- To identify the major challenges impacting long-term survival after lung transplantation.
- To highlight the importance of managing infection and rejection for improved patient outcomes.
Main Methods:
- Review of current literature on lung transplantation outcomes.
- Analysis of factors contributing to early and late morbidity and mortality.
- Discussion of the pathophysiology of infection and bronchiolitis obliterans syndrome.
Main Results:
- Lung transplant survival rates show improvement.
- Infection is the predominant cause of early and late complications.
- Bronchiolitis obliterans syndrome (BOS) is the second leading cause of late morbidity and mortality.
Conclusions:
- Effective management of infections is crucial for improving lung transplant outcomes.
- Addressing subclinical rejection and preventing infection are essential for enhancing intermediate and long-term survival.
- Further research into the multifactorial causes of BOS is needed to develop effective treatments.